Utilising patented VTP technology the Tear Science LipiFlow applies heat and pressure to the inner eyelid, optimising its ability to heat and clear the meibomian glands and safely rove gland obstructions and stagnant gland contents.Delivered through the LipiFlow Activator, VTP technology simultaneously maximises results and minimises discomfort. Patented vectored heat and adaptive force equalisation targets the pulse, heat, and pressure on the meibomian glands to maximize effectiveness.Therapeutic motion rolls from base to lid margin releasing stagnant contents from the glands.WATCH VIDEO
Research edges closer to an alternative for intravitreal drug delivery
A Charles Darwin University (CDU) researcher is one step closer to replacing intravitreal drug delivery for eye disease, as well...